It seems like others have mentioned that its mainly because of this news not circulating outside of the small group of people that follow this company and day traders that honestly have no idea of what they have in front of them.
Im puzzled to an extent too, but the more and more I look around it just seems like the above is why. Besides Endonovo's release of the news and a few websites running articles about it, there is no mention of the news anywhere else. Every day I'm looking at new postings on google to see if any articles are posted of significance with their results but nothing yet. But I cant see how once these results do reach medical journals and thousands and thousands of eyes take notice out of the blue that the price wont skyrocket.
Ive also been trying to look around to see what kind of "relevant scientific meeting" in 2018 they may be referring to. There is the 9th International Conference & Exhibition on Biosensors, Bioelectronics, and Biomedical Engineering September 24-25 next year in San Diego, just one possibility. Its close to them and by then would hopefully have results for all the other three pre-clinical studies plus a bunch of other possible updates and news. All my opinion, I've just been digging around the past few days, still planning on reaching out to Steve soon to ask a few things, mainly being their plans to publish info in medical journals or other methods of getting their results more publicly known, as well as updates on funding and what not.
But I definitely don't think its too far fetched for Mann to literally be fine with these prices as long as they last, allowing him to continue to make himself richer and richer one day while absorbing a little dilution.
All my opinion, good look to all us true longs, and fake longs and day traders as well, money is to be made for everyone. I sure as hell wouldn't want to risk waking up one morning though and not being loaded when they randomly release amazing funding or FDA updates, or even better, BOTH!
